Jump to content
The Twitter Feeds are now back on the Platform ×

4D Pharma hopes to expand drug success to other areas

Recommended Posts

With the recent success of 4D Pharma (DDDD) and its treatment for renal cell carcinoma (MRx0518 (518), IGTV’s Jeremy Naylor caught up with the company’s CEO, Duncan Peyton.

He said that this milestone releases more money onto DDDD’s balance sheet and enables the business to look to start testing other areas in which 518 could be used.




ig group.PNG

Link to comment

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Create New...